International Isotopes Total Liabilities 2010-2024 | INIS

International Isotopes total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
International Isotopes Annual Total Liabilities
(Millions of US $)
2024 $13
2023 $13
2022 $12
2021 $14
2020 $14
2019 $15
2018 $13
2017 $12
2016 $10
2015 $8
2014 $7
2013 $7
2012 $6
2011 $5
2010 $6
2009 $3
International Isotopes Quarterly Total Liabilities
(Millions of US $)
2024-12-31 $13
2024-09-30 $13
2024-06-30 $12
2024-03-31 $13
2023-12-31 $13
2023-09-30 $12
2023-06-30 $12
2023-03-31 $12
2022-12-31 $12
2022-09-30 $12
2022-06-30 $12
2022-03-31 $13
2021-12-31 $14
2021-09-30 $13
2021-06-30 $13
2021-03-31 $13
2020-12-31 $14
2020-09-30 $14
2020-06-30 $15
2020-03-31 $17
2019-12-31 $15
2019-09-30 $15
2019-06-30 $15
2019-03-31 $14
2018-12-31 $13
2018-09-30 $13
2018-06-30 $12
2018-03-31 $12
2017-12-31 $12
2017-09-30 $12
2017-06-30 $11
2017-03-31 $13
2016-12-31 $10
2016-09-30 $9
2016-06-30 $8
2016-03-31 $8
2015-12-31 $8
2015-09-30 $7
2015-06-30 $7
2015-03-31 $6
2014-12-31 $7
2014-09-30 $7
2014-06-30 $7
2014-03-31 $7
2013-12-31 $7
2013-09-30 $7
2013-06-30 $7
2013-03-31 $7
2012-12-31 $6
2012-09-30 $7
2012-06-30 $5
2012-03-31 $5
2011-12-31 $5
2011-09-30 $4
2011-06-30 $7
2011-03-31 $7
2010-12-31 $6
2010-09-30 $6
2010-06-30 $6
2010-03-31 $6
2009-12-31 $3
2009-09-30 $3
2009-06-30 $4
2009-03-31 $4
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.026B $0.014B
International Isotopes Inc., manufactures a full range of nuclear medicine calibration and reference standards, high purity fluoride gases, and a variety of cobalt-60 products such as teletherapy sources. The Company also provides a wide selection of radioisotopes and radiochemicals for medical devices, calibration, clinical research, life sciences, and industrial applications and provides a host of analytical, measurement, recycling, and processing services on a contract basis to clients.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $5.497B 15.05
Kewaunee Scientific (KEQU) United States $0.095B 6.71
Harvard Bioscience (HBIO) United States $0.017B 0.00